ChemoCentryx, Inc. Selling, General and Administrative Expense
ChemoCentryx, Inc. reported Selling, General and Administrative Expense of $28.18 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2022-08-08
- ChemoCentryx, Inc. selling, general and administrative expense for the quarter ending 2022-06-30 was $28.18M, a 43.06% increase year-over-year.
- ChemoCentryx, Inc. selling, general and administrative expense for the quarter ending 2022-03-31 was $26.01M, a 59.95% increase year-over-year.
- ChemoCentryx, Inc. selling, general and administrative expense for the quarter ending 2021-06-30 was $19.70M.
- ChemoCentryx, Inc. selling, general and administrative expense for the quarter ending 2021-03-31 was $16.26M.
- ChemoCentryx, Inc. selling, general and administrative expense for fiscal 2021 was $78.85M, a 86.91% increase from fiscal 2020.
- ChemoCentryx, Inc. selling, general and administrative expense for fiscal 2020 was $42.19M, a 74.65% increase from fiscal 2019.
- ChemoCentryx, Inc. selling, general and administrative expense for fiscal 2019 was $24.16M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|
| 2022-06-30 | $28.18M 10-Q · filed 2022-08-08 | $54.19M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $26.01M 10-Q · filed 2022-05-10 | ||
| 2021-12-31 | $78.85M 10-K · filed 2022-03-01 | ||
| 2021-06-30 | $19.70M 10-Q · filed 2022-08-08 | $35.96M 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $16.26M 10-Q · filed 2022-05-10 | ||
| 2020-12-31 | $42.19M 10-K · filed 2022-03-01 | ||
| 2019-12-31 | $24.16M 10-K · filed 2022-03-01 |